Concepedia

Anna Vossenkämper

AV

Statistics

Publications

28

Citations

2.8K

H-Index

26

Active since

2004

Affiliations

Queen Mary University of London(Current)

King's College London

Royal London Hospital

GlaxoSmithKline (United States)

Guy's and St Thomas' NHS Foundation Trust

Anna Vossenkämper is an author at Queen Mary University of London specializing in life sciences, inflammation, and immunology.

Publications per year

2004–2021

28

Publications

28

Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases

Philip A. Harris, Scott B. Berger, Jae Uk Jeong et al. · Journal of Medicinal Chemistry · 2017 · 475 citations · Full text

, , +15

Small Extracellular Vesicles Are Key Regulators of Non-cell Autonomous Intercellular Communication in Senescence via the Interferon Protein IFITM3

Michela Borghesan, Juan Fafián‐Labora, Olga Eleftheriadou et al. · Cell Reports · 2019 · 304 citations · Full text

, , +17

Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2

Alina Mares, Afjal H. Miah, Ian E. Smith et al. · Communications Biology · 2020 · 221 citations · Full text

, , +16

Developing in vitro expanded CD45RA<sup>+</sup>regulatory T cells as an adoptive cell therapy for Crohn's disease

James B. Canavan, Cristiano Scottà, Anna Vossenkämper et al. · Gut · 2015 · 194 citations · Full text

, , +17

Association of innate immune activation with latent Epstein-Barr virus in active MS lesions

John S. Tzartos, Gulfaraz Khan, Anna Vossenkämper et al. · Neurology · 2011 · 137 citations · Full text

, , +17

1–5 of 28